Topics

All Topics

On the Road

Automobile Accidents

Major Medical

Protecting Your Family

Defective & Dangerous Products

Miscellaneous

Miscellaneous

Zyprexa Class Action Now Includes 8 States

Shannon Weidemann

Contributor

Posted by Shannon WeidemannJuly 12, 2007 9:46 AM

1 Comment

Print Article

There are now eight states that have filed a class action lawsuit against Eli Lilly, the maker of the drug Zyprexa. The lawsuits have been filed because Eli Lilly allegedly advertised the drug for uses that were not approved by the FDA. They also claim that the drug manufacturer did not properly warn of potential side effects.

A representative from Myers' office confirmed Tuesday that Oregon "is part of the leadership states (Executive Committee) for a multi-state case concerning Eli Lilly and Zyprexa", Dawdy reported. Myers would use in-house staff rather than private lawyers as Montana recently did, the official added.
Just over two years ago, Indianapolis-based Eli Lilly announced it had paid around $690 million to settle claims, including class-action lawsuits, over claims it minimized Zyprexa's side-effects. But Lilly also warned it would fight other legal claims against Zyprexa.

The states claim the price of Zyprexa was artificially inflated by the company so their Medicare and Medicaid programs had to pay out higher claims.

For more information on this subject, please refer to our section on Drugs, Medical Devices, and Implants.

Tags: Class Action

1 Comment

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Posted by Sorrowful
July 16, 2007 8:04 AM

I hope all fifty states bring action against Lilly for Zyprexa, and especially that some states will also bring criminal charges. Many people died from this drug, including my only son, of profound hyperglycemia. This is a criminal act, especially because it is now known through obtaining internal documents, that Lilly knew perfectly well before putting Zyprexa on the market that it caused diabetes, hyperglycemia, and death.

And look out, states. Lilly and the other atypical makers are now going after children; gaining approval from their friends at the FDA to give the drugs to adolescents. Of course, Zyprexa and the others are already being given off-label to two million children as we speak (Cooper, Vanderbilt).